Notice of Proposed Sale · 144
Pharvaris N.V.
PHVSNASDAQEQUITYCurrent
Notice of Proposed Sale
Structured filing — 144
primary_doc.xml
Notice of proposed sale. The proposed amounts below do not establish that a sale occurred.
Proposed-sale notice
- Issuer
- Pharvaris N.V.
- Issuer CIK
- 0001830487
- SEC file number
- 001-40010
- Phone
- 310712036410
- Person for whose account securities are to be sold
- Berndt B.A,E. Modig
- Relationships to issuer
- Director · Officer
- Street
- Emmy Noetherweg 2
- City
- Leiden
- State / country code
- P7
- Postal code
- 2333 BK
Securities proposed for sale
| Security | Proposed units | Aggregate market value | Units outstanding | Approximate sale date | Exchange | Broker / market maker |
|---|---|---|---|---|---|---|
| Common | 2,292 | 80,380.44 | 65,407,822 | 07/13/2026 | NASDAQ | Morgan Stanley Smith Barney LLC Executive Financial Services |
Broker / market maker — proposed row 1, entry 1
- Name
- Morgan Stanley Smith Barney LLC Executive Financial Services
- Street
- 1 New York Plaza
- Street (continued)
- 8th Floor
- City
- New York
- State / country code
- NY
- Postal code
- 10004
Acquisition of securities to be sold
| Security | Acquired | Nature of acquisition | Acquired from | Amount acquired | Gift transaction | Payment date | Nature of payment |
|---|---|---|---|---|---|---|---|
| Common | 07/11/2026 | Restricted Stock Units | Issuer | 2,292 | N | 07/11/2026 | N/A |
Sales reported in the preceding three months
| Seller | Security | Sale date | Amount sold | Gross proceeds |
|---|---|---|---|---|
| 10b5-1 Sales for Berndt B.A.E. Modig | Common | 06/15/2026 | 2,291 | 71,172.89 |
| 10b5-1 Sales for Berndt B.A.E. Modig | Common | 05/15/2026 | 2,292 | 68,581.68 |
| 10b5-1 Sales for Berndt B.A.E. Modig | Common | 04/16/2026 | 2,292 | 65,558.53 |
Seller — prior-sale row 1, entry 1
- Name
- 10b5-1 Sales for Berndt B.A.E. Modig
- Street
- Emmy Noetherweg 2
- City
- Leiden
- State / country code
- P7
- Postal code
- 2333 BK
Seller — prior-sale row 2, entry 1
- Name
- 10b5-1 Sales for Berndt B.A.E. Modig
- Street
- Emmy Noetherweg 2
- City
- Leiden
- State / country code
- P7
- Postal code
- 2333 BK
Seller — prior-sale row 3, entry 1
- Name
- 10b5-1 Sales for Berndt B.A.E. Modig
- Street
- Emmy Noetherweg 2
- City
- Leiden
- State / country code
- P7
- Postal code
- 2333 BK
Prior-sale reporting
- Nothing to report for the preceding three months
- N
Remarks
The securities to be sold were acquired upon the vesting of restricted stock units during the period of 07/11/2026 through 07/12/2026.
Notice signature
- Notice date
- 07/13/2026
- Signed
- /s/ Berndt B.A,E. Modig
- Plan adoption dates
- 12/15/2025
Company context
Pharvaris is a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to help address unmet needs in bradykinin-mediated conditions, including all types of bradykinin-mediated angioedema. Pharvaris’ aspiration is to offer therapies with injectable-like efficacy™, a well-tolerated profile, and the convenience of oral administration to prevent and treat bradykinin-mediated angioedema attacks. By delivering on this aspiration, Pharvaris aims to provide a new standard of care in bradykinin-mediated angioedema. For more information, visit https://pharvaris.com/.